Inventor · disambiguated record
Gerhard Fries
Also filed as: FRIES GERHARD
7 granted patents·1 pending application·41 citations·filing 1990–2004
81Inventor score
Files withESPARMA GMBH4BIRD BEROLINA INNOVATIVE RES A1FAHLBERG LIST VEB1IMTM GMBH1SERUMWERK BERNBURG AG1
Top patents by PatentIndex Score
8 records- 0158US6719986B1Hyaluronate lyase used for promoting penetration in topical agentsESPARMA GMBH·Filed 1999·Granted Apr 13, 2004·19 cites·18 claims
- 0258US6518300B2Treatment of lipid metabolic disorders using 5-(1,2-dithiolan-3-yl) valeric acid (α-lipoic acid) or its physiologically compatible saltsBIRD BEROLINA INNOVATIVE RES A·Filed 2001·Granted Feb 11, 2003·3 cites·1 claims
- 0356US7429614B2Medicament containing an effector of the glutathione metabolism together with α-lipoic acid for treating diabetes mellitusESPARMA GMBH·Filed 2002·Granted Sep 30, 2008·1 cites·7 claims
- 0454US6689349B1Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysisESPARMA GMBH·Filed 1999·Granted Feb 10, 2004·15 cites·17 claims
- 0549US6413950B1Pharmaceutical preparation containing dithranolESPARMA GMBH·Filed 2000·Granted Jul 2, 2002·0 cites·6 claims
- 0642US2007212339A1Use Of At Least One Effector Of Glutathione Metabolism Together With Alpha-Lipoic Acid For The Treatment Of Chronically Obstructive Lung DiseasesIMTM GMBH·Filed 2004·Application pending·0 cites
- 0733US7531567B2Use of a medicament containing an effector of the glutathione metabolism together with α-lipoic acid in kidney replacement therapySERUMWERK BERNBURG AG·Filed 2002·Granted May 12, 2009·0 cites·21 claims
- 0827US5079265AComposition and methods for providing optimum bioavailability of the active ingredient 2-hydroxy-5-methyllaurophenoxime (hmlo)FAHLBERG LIST VEB·Filed 1990·Granted Jan 7, 1992·3 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Gerhard Fries files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →